Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

26.58

+2.09 (8.53%)

At close: Oct 9, 2026, 4:00 PM EDT

26.45

-0.13 (-0.49%)

After-hours: Oct 9, 2026, 7:47 PM EDT

Arcutis Biotherapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	463.98	376.07	196.54	59.61	3.69	-
Revenue Growth	76.11%	91.34%	229.73%	1517.09%	-	-
Gross Profit	422.89	339.38	177.41	54.62	2.93	-
Operating Income	34.25	-12.23	-128.4	-241.1	-301.63	-206.53
Net Income	28.52	-16.14	-140.04	-262.14	-311.46	-206.36
Earnings Per Share	0.22	-0.13	-1.16	-3.78	-5.66	-4.18
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
ZORYVE Cream 0.3%	137.93	121	85.08	29.19	3.69
ZORYVE Foam	229.44	181.89	71.54	-	-
ZORYVE Cream 0.15%	89.41	68.27	9.92	-	-
ZORYVE Cream 0.05%	-	0.91	-	-	-
Other Segment	-	4	30	30.42	-
Revenue (Total)	463.98	376.07	196.54	59.61	3.69

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	238.55	220.98	227.96	271.86	409.59	387.06
Total Debt	114.14	114.52	109.77	205.92	202.54	77.56
Net Cash (Debt)	124.42	106.46	118.19	65.95	207.05	309.5
Net Cash Growth	54.25%	-9.92%	79.22%	-68.15%	-33.10%	10.74%
Net Cash Per Share	0.94	0.84	0.98	0.95	3.76	6.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	39.31	-5.63	-112.16	-247.06	-257.72	-174.63
Capital Expenditures	-0.16	-0.69	-0.14	-0.43	-0.33	-1
Free Cash Flow	39.15	-6.31	-112.3	-247.49	-258.05	-175.62
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	91.14%	90.24%	90.27%	91.63%	79.54%	-
Operating Margin	7.38%	-3.25%	-65.33%	-404.49%	-8183.04%	-
Pretax Margin	6.31%	-3.98%	-70.92%	-434.57%	-8449.76%	-
Profit Margin	6.15%	-4.29%	-71.25%	-439.79%	-8449.76%	-
FCF Margin	8.44%	-1.68%	-57.14%	-415.20%	-7000.76%	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	37.23	76.62	-	-	-	-
PS Ratio	7.20	9.46	8.30	5.11	244.56	-